ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE) Trial

Project: Research project

Project Details


Northwestern University will be responsible for conducting the ADVISE Trial according to ICH Good Clinical Practice Guidelines, which includes obtaining appropriate regulatory approvals; completing study personnel and clinic certification, following the procedures described in the study protocol for evaluation, enrollment, treatment, and follow-up of study subjects; expedited reporting of urgent safety matters to CC; ensuring that subjects’ Protected Health Information remains confidential; and that study data are accurate, complete, and submitted to the CC in a timely manner.
Effective start/end date9/30/198/31/24


  • Johns Hopkins University (2004591747 Amendment 4 // 5UG1EY028091-05)
  • National Eye Institute (2004591747 Amendment 4 // 5UG1EY028091-05)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.